thyroxine has been researched along with Menopause in 78 studies
Thyroxine: The major hormone derived from the thyroid gland. Thyroxine is synthesized via the iodination of tyrosines (MONOIODOTYROSINE) and the coupling of iodotyrosines (DIIODOTYROSINE) in the THYROGLOBULIN. Thyroxine is released from thyroglobulin by proteolysis and secreted into the blood. Thyroxine is peripherally deiodinated to form TRIIODOTHYRONINE which exerts a broad spectrum of stimulatory effects on cell metabolism.
thyroxine : An iodothyronine compound having iodo substituents at the 3-, 3'-, 5- and 5'-positions.
Menopause: The last menstrual period. Permanent cessation of menses (MENSTRUATION) is usually defined after 6 to 12 months of AMENORRHEA in a woman over 45 years of age. In the United States, menopause generally occurs in women between 48 and 55 years of age.
| Excerpt | Relevance | Reference |
|---|---|---|
| "A randomized clinical trial was performed in consecutive patients with sporadic nontoxic nodular goiter to compare efficacy and side effects of iodine-131 ((131)I) therapy with suppressive levothyroxine (L-thyroxine) treatment." | 9.09 | A randomized trial comparing levothyroxine with radioactive iodine in the treatment of sporadic nontoxic goiter. ( Lips, P; Smits, NJ; Tiel-V Buul, MM; Wesche, MF; Wiersinga, WM, 2001) |
| "Various plasma hormones were measured in 13 pre- and 20 post-menopausal women with advanced breast cancer before and for 12 months after ovarian irradiation or during continuous administration of tamoxifen at a dose of 10 mg twice a day, respectively; some patients received additional prednisolone at a dose of 5 mg twice a day." | 9.05 | Effect of prednisolone on hormone profiles during primary endocrine treatment of advanced breast cancer. ( Blackburn, AM; Bulbrook, RD; Hoare, SA; Kwa, HG; Rubens, RD; Thomas, BS; Wang, DY, 1984) |
| "Aminoglutethimide is effective in the treatment of breast cancer in postmenopausal patients as a result of its inhibition of aromatase." | 7.68 | Low-dose aminoglutethimide in postmenopausal breast cancer: effects on adrenal and thyroid hormone secretion. ( Cantwell, BM; Dowsett, M; Harris, AL; Mehta, A, 1991) |
| " While this regimen effectively blocked adrenal function, it was complicated by a drug interaction in which aminoglutethimide accelerated the metabolism and reduced the bioavailability of dexamethasone." | 6.36 | Kinetic, hormonal and clinical studies with aminoglutethimide in breast cancer. ( Harvey, H; Kendall, J; Lipton, A; Ruby, EB; Samojlik, E; Santen, RJ; Wells, SA, 1977) |
| "Conventional risk factors for NAFLD were assessed as well as serum levels of TSH, FT3 and FT4." | 5.42 | Free triiodothyronine levels are positively associated with non-alcoholic fatty liver disease in euthyroid middle-aged subjects. ( Guan, L; Guan, Q; Jiang, Q; Jiang, Z; Lin, H; Liu, G; Yu, C; Zhang, N; Zhang, X; Zhang, Y; Zheng, X, 2015) |
| "Many studies have found clinical and metabolic alterations in subclinical hypothyroidism, however, there are disagreements about the benefits of levothyroxine therapy." | 5.13 | Treatment of subclinical hypothyroidism reduces atherogenic lipid levels in a placebo-controlled double-blind clinical trial. ( Almeida, CP; Buescu, A; Costa, AJ; Ferreira, MM; Melo, BA; Reis, FA; Reuters, VS; Teixeira, PF; Vaisman, M, 2008) |
| "In a randomized, controlled study, 59 euthyroid women with surgical menopause were randomized to an estrogen-only (n=20), tibolone (n=20) or calcium-only (n=19) group." | 5.12 | Effect of different hormonal therapies on thyroid function in surgical menopause: short-term results. ( Erel, CT; Gezer, A; Kaleli, S; Sentürk, LM; Seyisoglu, H; Somunkiran, A, 2007) |
| "A randomized clinical trial was performed in consecutive patients with sporadic nontoxic nodular goiter to compare efficacy and side effects of iodine-131 ((131)I) therapy with suppressive levothyroxine (L-thyroxine) treatment." | 5.09 | A randomized trial comparing levothyroxine with radioactive iodine in the treatment of sporadic nontoxic goiter. ( Lips, P; Smits, NJ; Tiel-V Buul, MM; Wesche, MF; Wiersinga, WM, 2001) |
| "Various plasma hormones were measured in 13 pre- and 20 post-menopausal women with advanced breast cancer before and for 12 months after ovarian irradiation or during continuous administration of tamoxifen at a dose of 10 mg twice a day, respectively; some patients received additional prednisolone at a dose of 5 mg twice a day." | 5.05 | Effect of prednisolone on hormone profiles during primary endocrine treatment of advanced breast cancer. ( Blackburn, AM; Bulbrook, RD; Hoare, SA; Kwa, HG; Rubens, RD; Thomas, BS; Wang, DY, 1984) |
| " The aim of this study was analysis of cognitive function levels in reference to thyroid examination: thyroid-stimulating hormone (TSH), total thyroxin (TT4), triiodothyronine (TT3), free thyroxin (FT4), free triiodothyronine (FT3), thyroperoxidase antibodies (TPO-AB), and thyroglobulin antibodies (Tg-AB), TSH receptor antibodies (AB-TSHR) in women after menopause." | 3.81 | Functional status of thyroid and cognitive functions after menopause. ( Bojar, I; Gnatowski, M; Gujski, M; Owoc, A; Walecka, I; Witczak, M, 2015) |
| " We assessed the subjects according to the Simplified Menopause Index, menstrual status, thyroid hormone measurements (thyroid stimulating hormone, free thyroxine, free triiodothyronine), the presence of Hashimoto's disease antibodies (anti-thyroid peroxidase antibody or anti-thyroglobulin antibody), the presence of Grave's disease (anti-TSH receptor antibody), markers of thyroid tumor (high thyroglobulin), and thyroid ultrasonography studies." | 3.79 | Comparison of the symptoms of menopause and symptoms of thyroid disease in Japanese women aged 35-59 years. ( Ohi, K; Oi, N, 2013) |
| "This study evaluated changes of lipids and lipoprotein (a) [Lp (a)] as atherosclerotic risk factors and the effects of levothyroxine (LT4) treatment on these parameters in patient with subclinical hypothyroidism (SH), defined by increased concentrations of thyrotropin (TSH) and normal thyroid hormone concentrations." | 3.72 | Lipid profile and lipoprotein (a) as a risk factor for cardiovascular disease in women with subclinical hypothyroidism. ( Canturk, NZ; Canturk, Z; Cetinarslan, B; Ozden, M; Tarkun, I, 2003) |
| "Aminoglutethimide is effective in the treatment of breast cancer in postmenopausal patients as a result of its inhibition of aromatase." | 3.68 | Low-dose aminoglutethimide in postmenopausal breast cancer: effects on adrenal and thyroid hormone secretion. ( Cantwell, BM; Dowsett, M; Harris, AL; Mehta, A, 1991) |
| "Serum tri-iodothyronine (T3), thyroxine (T4) and thyroid-stimulating hormone (TSH) concentrations were measured in 50 postmenopausal patients with breast cancer receiving tamoxifen therapy." | 3.67 | The effect of tamoxifen therapy on thyroid function tests. ( Beastall, GH; Gordon, D; McArdle, CS; Thomson, JA, 1986) |
| "Levels of circulating estrone (E1), estradiol (E2), androst-4-ene-3,17-dione (Adione), 3,5,3'-triiodothyronine (T3), thyroxine (T4), and sex hormone-binding globulin (SHBG) were measured in 10 obese postmenopausal patients with breast cancer and in 10 obese postmenopausal control subjects matched for age, body size, and menopausal status." | 3.67 | Decrease of circulating level of SHBG in postmenopausal obese women as a risk factor in breast cancer: reversible effect of weight loss. ( Cardillo, LR; del Carmen Cremona, M; Enriori, CL; Etkin, AE; Orsini, W; Reforzo-Membrives, J, 1986) |
| "Serum levels of thyroid-stimulating hormone (TSH), triiodothyronine (T3), thyroxine (T4), free triidotthyronine (FT3), free thyroxine (FT4) and thyroxine-binding globulin (TBG) were measured in 382 healthy women who were attending a menopause clinic." | 3.66 | A study of thyroid function in the pre- and post-menopause. ( Bottiglioni, F; Capelli, M; de Aloysio, D; Mantuano, R; Mauloni, M; Nicoletti, G, 1983) |
| " A significant dose-response was not found." | 2.42 | The effect of levothyroxine therapy on bone mineral density: a systematic review of the literature. ( Reiners, C; Schneider, R, 2003) |
| " While this regimen effectively blocked adrenal function, it was complicated by a drug interaction in which aminoglutethimide accelerated the metabolism and reduced the bioavailability of dexamethasone." | 2.36 | Kinetic, hormonal and clinical studies with aminoglutethimide in breast cancer. ( Harvey, H; Kendall, J; Lipton, A; Ruby, EB; Samojlik, E; Santen, RJ; Wells, SA, 1977) |
| "Conventional risk factors for NAFLD were assessed as well as serum levels of TSH, FT3 and FT4." | 1.42 | Free triiodothyronine levels are positively associated with non-alcoholic fatty liver disease in euthyroid middle-aged subjects. ( Guan, L; Guan, Q; Jiang, Q; Jiang, Z; Lin, H; Liu, G; Yu, C; Zhang, N; Zhang, X; Zhang, Y; Zheng, X, 2015) |
| "Hypothyroidism is more frequent in woman and raises with age." | 1.35 | [Hypothyroidism associated to menopause symptoms worsening change with thyroid substitution therapy]. ( Basurto, L; Córdova Pérez, N; Hernández Valencia, M; Manuel Apolinar, L; Ruiz, M; Vargas, A; Vargas, C; Zárate, A, 2008) |
| "Treatment with 131I for differentiated thyroid cancer may give a follicle-damaging radiation dose to the ovaries." | 1.31 | 131I therapy for differentiated thyroid cancer leads to an earlier onset of menopause: results of a retrospective study. ( Bencivelli, W; Ceccarelli, C; Morciano, D; Pacini, F; Pinchera, A, 2001) |
| "The prevalence of hypothyroidism has been reported to increase with age and to attain up to 10% in older women." | 1.29 | Screening for thyroid disease at the menopausal clinic. ( Bissonnette, F; Brossard, JH; D'Amour, P; Faughnan, M; Fugère, P; Lepage, R, 1995) |
| "When patients with previously treated Graves' disease (n = 4 in each group) were eliminated, the differences in bone density at the hip were no longer seen." | 1.28 | Skeletal integrity in premenopausal and postmenopausal women receiving long-term L-thyroxine therapy. ( Block, JE; Friedlander, AL; Genant, HK; Greenspan, FS; Greenspan, SL; Resnick, NM, 1991) |
| "Toremifene was given within the dose range of 3-680 mg as a single dose or on five consecutive days to 72 postmenopausal volunteers." | 1.28 | Effect of toremifene on clinical chemistry, hematology and hormone levels at different doses in healthy postmenopausal volunteers: phase I study. ( Kivinen, S; Mäenpää, J, 1990) |
| " It is advisable, therefore, to employ a dosage of L-T4 that is carefully monitored to avoid the long-term use of dosages that are excessive for the thyroid condition being treated." | 1.27 | Long-term L-thyroxine therapy is associated with decreased hip bone density in premenopausal women. ( Baran, DT; Braverman, LE; Kelly, AM; Kerrigan, J; Paul, TL, 1988) |
| "In 20 patients with primary hypothyroidism mean serum hTSH-beta was 1." | 1.25 | Pituitary secretion of free alpha and beta subunit of human thyrotropin in patients with thyroid disorders. ( Kourides, IA; Maloof, F; Ridgway, EC; Weintraub, BD, 1975) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 37 (47.44) | 18.7374 |
| 1990's | 22 (28.21) | 18.2507 |
| 2000's | 13 (16.67) | 29.6817 |
| 2010's | 4 (5.13) | 24.3611 |
| 2020's | 2 (2.56) | 2.80 |
| Authors | Studies |
|---|---|
| Slopien, R | 1 |
| Owecki, M | 1 |
| Slopien, A | 1 |
| Bala, G | 1 |
| Meczekalski, B | 1 |
| Sousa, BÉCA | 1 |
| Silva, BC | 1 |
| de Oliveira Guidotti, T | 1 |
| Pires, MC | 1 |
| Soares, MMS | 1 |
| Kakehasi, AM | 1 |
| Tournis, S | 1 |
| Antoniou, JD | 1 |
| Liakou, CG | 1 |
| Christodoulou, J | 1 |
| Papakitsou, E | 1 |
| Galanos, A | 1 |
| Makris, K | 1 |
| Marketos, H | 1 |
| Nikopoulou, S | 1 |
| Tzavara, I | 1 |
| Triantafyllopoulos, IK | 1 |
| Dontas, I | 1 |
| Papaioannou, N | 1 |
| Lyritis, GP | 1 |
| Alevizaki, M | 1 |
| Liu, G | 1 |
| Zheng, X | 1 |
| Guan, L | 1 |
| Jiang, Z | 1 |
| Lin, H | 1 |
| Jiang, Q | 1 |
| Zhang, N | 1 |
| Zhang, Y | 1 |
| Zhang, X | 1 |
| Yu, C | 1 |
| Guan, Q | 1 |
| Bojar, I | 1 |
| Owoc, A | 1 |
| Gujski, M | 1 |
| Witczak, M | 1 |
| Gnatowski, M | 1 |
| Walecka, I | 1 |
| Hernández Valencia, M | 1 |
| Córdova Pérez, N | 1 |
| Zárate, A | 1 |
| Basurto, L | 1 |
| Manuel Apolinar, L | 1 |
| Ruiz, M | 1 |
| Vargas, C | 1 |
| Vargas, A | 1 |
| Oi, N | 1 |
| Ohi, K | 1 |
| Loviselli, A | 1 |
| Rizzolo, E | 1 |
| Mastinu, R | 1 |
| Velluzzi, F | 1 |
| Secci, G | 1 |
| Taberlet, A | 1 |
| Mariotti, S | 1 |
| SPENCE, AW | 1 |
| Canturk, Z | 1 |
| Cetinarslan, B | 1 |
| Tarkun, I | 1 |
| Canturk, NZ | 1 |
| Ozden, M | 1 |
| Schneider, R | 1 |
| Reiners, C | 1 |
| Babińska, A | 1 |
| Wiśniewski, P | 1 |
| Sworczak, K | 1 |
| Pearce, EN | 1 |
| Teixeira, PF | 1 |
| Reuters, VS | 1 |
| Ferreira, MM | 1 |
| Almeida, CP | 1 |
| Reis, FA | 1 |
| Melo, BA | 1 |
| Buescu, A | 1 |
| Costa, AJ | 1 |
| Vaisman, M | 1 |
| Erel, CT | 1 |
| Gezer, A | 1 |
| Sentürk, LM | 1 |
| Somunkiran, A | 1 |
| Kaleli, S | 1 |
| Seyisoglu, H | 1 |
| Blackburn, AM | 1 |
| Wang, DY | 1 |
| Bulbrook, RD | 1 |
| Thomas, BS | 1 |
| Kwa, HG | 1 |
| Hoare, SA | 1 |
| Rubens, RD | 1 |
| Bottiglioni, F | 1 |
| de Aloysio, D | 1 |
| Nicoletti, G | 1 |
| Mauloni, M | 1 |
| Mantuano, R | 1 |
| Capelli, M | 1 |
| Abdalla, HI | 1 |
| Hart, DM | 1 |
| Beastall, GH | 2 |
| Balan, VE | 1 |
| Gordon, M | 1 |
| Gryfe, CI | 1 |
| Faughnan, M | 1 |
| Lepage, R | 1 |
| Fugère, P | 1 |
| Bissonnette, F | 1 |
| Brossard, JH | 1 |
| D'Amour, P | 1 |
| Dryzhak, VI | 1 |
| Földes, J | 1 |
| Tarján, G | 1 |
| Szathmari, M | 1 |
| Varga, F | 1 |
| Krasznai, I | 1 |
| Horvath, C | 1 |
| Gutowski, NJ | 1 |
| Heron, JR | 1 |
| Ongphiphadhanakul, B | 1 |
| Puavilai, G | 1 |
| Rajatanavin, R | 1 |
| Gyulai, L | 1 |
| Jaggi, J | 1 |
| Bauer, MS | 1 |
| Younkin, S | 1 |
| Rubin, L | 1 |
| Attie, M | 1 |
| Whybrow, PC | 1 |
| Pop, VJ | 1 |
| Maartens, LH | 1 |
| Leusink, G | 1 |
| van Son, MJ | 1 |
| Knottnerus, AA | 1 |
| Ward, AM | 1 |
| Metcalfe, R | 1 |
| Weetman, AP | 1 |
| Rachedi, F | 1 |
| Rohmer, V | 1 |
| Six, P | 1 |
| Duquenne, M | 1 |
| Wion Barbot, N | 1 |
| Minebois, A | 1 |
| Bigorgne, JC | 1 |
| Audran, M | 1 |
| Peterson, DD | 1 |
| Schmidt, RM | 1 |
| Bellipanni, G | 1 |
| Bianchi, P | 1 |
| Pierpaoli, W | 1 |
| Bulian, D | 1 |
| Ilyia, E | 1 |
| Wesche, MF | 1 |
| Tiel-V Buul, MM | 1 |
| Lips, P | 1 |
| Smits, NJ | 1 |
| Wiersinga, WM | 1 |
| Ceccarelli, C | 1 |
| Bencivelli, W | 1 |
| Morciano, D | 1 |
| Pinchera, A | 1 |
| Pacini, F | 1 |
| Lindblom, P | 1 |
| Valdemarsson, S | 1 |
| Lindergård, B | 1 |
| Westerdahl, J | 1 |
| Bergenfelz, A | 1 |
| Serraclara, A | 1 |
| Jódar, E | 1 |
| Sarabia, F | 1 |
| Hawkins, F | 1 |
| Smallridge, RC | 1 |
| Wartofsky, L | 2 |
| Dimond, RC | 2 |
| Santen, RJ | 2 |
| Samojlik, E | 1 |
| Lipton, A | 2 |
| Harvey, H | 2 |
| Ruby, EB | 1 |
| Wells, SA | 2 |
| Kendall, J | 1 |
| Medeiros-Neto, GA | 1 |
| Knobel, M | 1 |
| Barros, A | 1 |
| de Ulhoa Cintra, AB | 1 |
| Rutlin, E | 1 |
| Haug, E | 1 |
| Torjesen, PA | 1 |
| Haagensen, DE | 1 |
| Ruby, EJ | 1 |
| Dilley, WG | 1 |
| Lee, SG | 1 |
| Lundy, LE | 1 |
| Kashef, M | 1 |
| Dorn, J | 1 |
| Hall, R | 1 |
| Gomez-Pan, A | 1 |
| Malarkey, WB | 1 |
| Schroeder, LL | 1 |
| Stevens, VC | 1 |
| James, AG | 1 |
| Lanese, RR | 1 |
| Hullin, RP | 1 |
| McDonald, R | 1 |
| Allsopp, MN | 1 |
| Kourides, IA | 1 |
| Weintraub, BD | 1 |
| Ridgway, EC | 1 |
| Maloof, F | 1 |
| Franklyn, JA | 1 |
| Betteridge, J | 1 |
| Daykin, J | 1 |
| Holder, R | 1 |
| Oates, GD | 1 |
| Parle, JV | 1 |
| Lilley, J | 1 |
| Heath, DA | 1 |
| Sheppard, MC | 1 |
| Rossmanith, WG | 2 |
| Stäbler, C | 1 |
| Benz, R | 1 |
| Bornstein, SR | 1 |
| Scherbaum, WA | 2 |
| Astrup, A | 1 |
| Buemann, B | 1 |
| Christensen, NJ | 1 |
| Madsen, J | 1 |
| Gluud, C | 1 |
| Bennett, P | 1 |
| Svenstrup, B | 1 |
| Pioli, G | 1 |
| Pedrazzoni, M | 1 |
| Palummeri, E | 1 |
| Sianesi, M | 1 |
| Del Frate, R | 1 |
| Vescovi, PP | 1 |
| Prisco, M | 1 |
| Ulietti, V | 1 |
| Costi, D | 1 |
| Passeri, M | 1 |
| Szilagyi, A | 1 |
| Chute, J | 1 |
| Shakir, KM | 1 |
| Lehmke, J | 1 |
| Bogner, U | 1 |
| Felsenberg, D | 1 |
| Peters, H | 1 |
| Schleusener, H | 1 |
| Dowsett, M | 1 |
| Mehta, A | 1 |
| Cantwell, BM | 1 |
| Harris, AL | 1 |
| Greenspan, SL | 1 |
| Greenspan, FS | 1 |
| Resnick, NM | 1 |
| Block, JE | 1 |
| Friedlander, AL | 1 |
| Genant, HK | 1 |
| Adlin, EV | 1 |
| Maurer, AH | 1 |
| Marks, AD | 1 |
| Channick, BJ | 1 |
| Diamond, T | 1 |
| Nery, L | 1 |
| Hales, I | 1 |
| Kivinen, S | 1 |
| Mäenpää, J | 1 |
| Gebhart, SS | 1 |
| Watts, NB | 1 |
| Clark, RV | 1 |
| Umpierrez, G | 1 |
| Sgoutas, D | 1 |
| Takatani, O | 1 |
| Okumoto, T | 1 |
| Kosano, H | 1 |
| Nishida, M | 1 |
| Hiraide, H | 1 |
| Tamakuma, S | 1 |
| Custro, N | 1 |
| Scafidi, V | 1 |
| Celani, MF | 1 |
| Giambuzzi, G | 1 |
| Simoni, M | 1 |
| Montanini, V | 1 |
| Kissebah, AH | 1 |
| Schectman, G | 1 |
| Paul, TL | 1 |
| Kerrigan, J | 1 |
| Kelly, AM | 1 |
| Braverman, LE | 1 |
| Baran, DT | 1 |
| Rachev, E | 1 |
| Zakharieva, B | 1 |
| Vasilev, D | 1 |
| Gordon, D | 1 |
| McArdle, CS | 1 |
| Thomson, JA | 1 |
| Krølner, B | 1 |
| Quint, AR | 1 |
| Kaiser, FE | 1 |
| Dogliotti, L | 1 |
| Faggiuolo, R | 1 |
| Ferusso, A | 1 |
| Orlandi, F | 1 |
| Sandrucci, S | 1 |
| Tibo, A | 1 |
| Angeli, A | 1 |
| Oberkotter, LV | 1 |
| Farmer, LC | 1 |
| Farber, M | 1 |
| Enriori, CL | 1 |
| Orsini, W | 1 |
| del Carmen Cremona, M | 1 |
| Etkin, AE | 1 |
| Cardillo, LR | 1 |
| Reforzo-Membrives, J | 1 |
| Robboy, MS | 1 |
| Sato, AS | 1 |
| Schwabe, AD | 1 |
| Caplan, RH | 1 |
| Dobben, GD | 1 |
| Kolendorf, K | 1 |
| Siersbaek-Nielsen, K | 1 |
| Hansen, MJ | 1 |
| Friis, T | 1 |
| Heath, H | 1 |
| Lee, RB | 1 |
| Tulchinsky, D | 1 |
| Chopra, IJ | 1 |
| Pérez-Vega, E | 1 |
| Aguilar-Parada, E | 1 |
| Kato-Kato, A | 1 |
| Ibarra, A | 1 |
| Cropp, GJ | 1 |
| Myers, DN | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Predicting Adaptive Thermogenesis[NCT00687115] | Phase 2 | 83 participants (Actual) | Interventional | 2008-09-18 | Completed | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
7 reviews available for thyroxine and Menopause
| Article | Year |
|---|---|
The effect of levothyroxine therapy on bone mineral density: a systematic review of the literature.
Topics: Age Factors; Bone Density; Cohort Studies; Cross-Sectional Studies; Dose-Response Relationship, Drug | 2003 |
[Contemporary view on subclinical hyperthyroidism].
Topics: Bone Diseases, Metabolic; Causality; Comorbidity; Female; Humans; Hyperthyroidism; Male; Menopause; | 2006 |
Thyroid dysfunction in perimenopausal and postmenopausal women.
Topics: Female; Humans; Hypothyroidism; Menopause; Thyroid Function Tests; Thyrotoxicosis; Thyrotropin; Thyr | 2007 |
Kinetic, hormonal and clinical studies with aminoglutethimide in breast cancer.
Topics: Adrenocorticotropic Hormone; Aldosterone; Aminoglutethimide; Androstenedione; Breast Neoplasms; Dehy | 1977 |
The hypothalamic regulatory hormones and their clinical applications.
Topics: Female; Follicle Stimulating Hormone; Gastrins; Glucagon; Gonadotropin-Releasing Hormone; Humans; Hy | 1976 |
Hormones and lipoprotein metabolism.
Topics: Catecholamines; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Female; Glucagon; Glucocortico | 1987 |
Lumbar spine bone mineral content by photon beam absorptiometry. Methodology and application in osteoporosis.
Topics: Aging; Female; Fractures, Bone; Humans; Hyperthyroidism; Lumbar Vertebrae; Menopause; Methods; Miner | 1985 |
6 trials available for thyroxine and Menopause
| Article | Year |
|---|---|
Treatment of subclinical hypothyroidism reduces atherogenic lipid levels in a placebo-controlled double-blind clinical trial.
Topics: Atherosclerosis; Double-Blind Method; Female; Humans; Hypothyroidism; Lipid Metabolism; Male; Menopa | 2008 |
Effect of different hormonal therapies on thyroid function in surgical menopause: short-term results.
Topics: Adult; Calcium; Estrogen Receptor Modulators; Estrogen Replacement Therapy; Estrogens; Estrogens, Co | 2007 |
Effect of prednisolone on hormone profiles during primary endocrine treatment of advanced breast cancer.
Topics: Breast Neoplasms; Clinical Trials as Topic; Dehydroepiandrosterone; Dehydroepiandrosterone Sulfate; | 1984 |
Reduced serum free thyroxine concentration in postmenopausal women receiving oestrogen treatment.
Topics: Female; Humans; Menopause; Mestranol; Middle Aged; Thyrotropin; Thyroxine; Thyroxine-Binding Protein | 1984 |
Effects of melatonin in perimenopausal and menopausal women: a randomized and placebo controlled study.
Topics: Adult; Affect; Circadian Rhythm; Depression; Double-Blind Method; Female; Follicle Stimulating Hormo | 2001 |
A randomized trial comparing levothyroxine with radioactive iodine in the treatment of sporadic nontoxic goiter.
Topics: Bone Density; Bone Remodeling; Female; Goiter; Humans; Hypothyroidism; Iodine Radioisotopes; Male; M | 2001 |
65 other studies available for thyroxine and Menopause
| Article | Year |
|---|---|
Climacteric symptoms are related to thyroid status in euthyroid menopausal women.
Topics: Adult; Aged; Biomarkers; Climacteric; Female; Follow-Up Studies; Humans; Menopause; Middle Aged; Pro | 2020 |
Trabecular bone score in women with differentiated thyroid cancer on long-term TSH-suppressive therapy.
Topics: Adenocarcinoma; Adolescent; Adult; Aged; Aged, 80 and over; Bone Density; Brazil; Cancellous Bone; C | 2021 |
Volumetric bone mineral density and bone geometry assessed by peripheral quantitative computed tomography in women with differentiated thyroid cancer under TSH suppression.
Topics: Adult; Bone and Bones; Bone Density; Case-Control Studies; Cone-Beam Computed Tomography; Female; Ho | 2015 |
Free triiodothyronine levels are positively associated with non-alcoholic fatty liver disease in euthyroid middle-aged subjects.
Topics: Adult; China; Comorbidity; Female; Humans; Male; Menopause; Metabolic Syndrome; Middle Aged; Non-alc | 2015 |
Functional status of thyroid and cognitive functions after menopause.
Topics: Analysis of Variance; Attention; Cognition; Executive Function; Female; Humans; Menopause; Middle Ag | 2015 |
[Hypothyroidism associated to menopause symptoms worsening change with thyroid substitution therapy].
Topics: Female; Hormone Replacement Therapy; Humans; Hypothyroidism; Longitudinal Studies; Menopause; Middle | 2008 |
Comparison of the symptoms of menopause and symptoms of thyroid disease in Japanese women aged 35-59 years.
Topics: Adult; Arrhythmias, Cardiac; Autoantibodies; Diagnosis, Differential; Female; Flushing; Graves Disea | 2013 |
High serum circulating telopeptide type I in multinodular goiter.
Topics: Adult; Aged; Biomarkers; Collagen Type I; Female; Goiter, Nodular; Humans; Hyperthyroidism; Menopaus | 2003 |
HORMONAL DISTURBANCES IN THE ELDERLY.
Topics: Aged; Aging; Androgens; Calcium; Calcium, Dietary; Diethylstilbestrol; Endocrinology; Erectile Dysfu | 1964 |
Lipid profile and lipoprotein (a) as a risk factor for cardiovascular disease in women with subclinical hypothyroidism.
Topics: Adult; Blood Glucose; Blood Pressure; Cardiovascular Diseases; Case-Control Studies; Cholesterol; Es | 2003 |
A study of thyroid function in the pre- and post-menopause.
Topics: Adult; Aging; Climacteric; Female; Humans; Menopause; Middle Aged; Thyroid Gland; Thyrotropin; Thyro | 1983 |
[Function of the thyrotropic-thyroid system in physiological and pathological climacteric].
Topics: Adult; Climacteric; Female; Humans; Menopause; Menstruation; Middle Aged; Pituitary Gland, Anterior; | 1983 |
Hyperthyroidism with painless subacute thyroiditis in the elderly.
Topics: Age Factors; Aged; Female; Humans; Hyperthyroidism; Menopause; Middle Aged; Pain; Syndrome; Thyroidi | 1981 |
Screening for thyroid disease at the menopausal clinic.
Topics: Ambulatory Care Facilities; Autoantibodies; Biomarkers; Female; Humans; Hypothyroidism; Mass Screeni | 1995 |
[Thyroid function in breast cancer patients].
Topics: Adult; Breast Neoplasms; Female; Humans; Menopause; Middle Aged; Radioimmunoassay; Thyroid Gland; Th | 1993 |
Bone mineral density in patients with endogenous subclinical hyperthyroidism: is this thyroid status a risk factor for osteoporosis?
Topics: Adult; Aged; Bone Density; Cross-Sectional Studies; Female; Femur Neck; Goiter, Nodular; Humans; Hyp | 1993 |
Recurrent confusion and hypopituitarism.
Topics: Confusion; Female; Humans; Hydrocortisone; Hypopituitarism; Menopause; Middle Aged; Recurrence; Thyr | 1993 |
Effect of TSH-suppressive doses of levothyroxine on bone mineral density in Thai women.
Topics: Absorptiometry, Photon; Adult; Aged; Bone Density; Female; Humans; Menopause; Middle Aged; Thailand; | 1996 |
Bone mineral density and L-thyroxine treatment in rapidly cycling bipolar disorder.
Topics: Adult; Bipolar Disorder; Bone Density; Cross-Sectional Studies; Female; Humans; Menopause; Middle Ag | 1997 |
Are autoimmune thyroid dysfunction and depression related?
Topics: Autoantibodies; Autoimmune Diseases; Cohort Studies; Depression; Female; Humans; Hyperthyroidism; Hy | 1998 |
[Prolonged suppressive L-thyroxine therapy. Longitudinal study of the effect of LT4 on bone mineral density and bone metabolism markers in 71 patients].
Topics: Adult; Bone Density; Bone Remodeling; Calcification, Physiologic; Estrogen Replacement Therapy; Fema | 1999 |
Longitudinal and cross-sectional analysis of HEALTH WATCH data with a subset of perimenopausal women and matched controls.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Aging; Alkaline Phosphatase; Case-Control Studies; Cohor | 1999 |
131I therapy for differentiated thyroid cancer leads to an earlier onset of menopause: results of a retrospective study.
Topics: Adult; Age Factors; Combined Modality Therapy; Female; Follow-Up Studies; Goiter; Humans; Iodine Rad | 2001 |
Decreased levels of ionized calcium one year after hemithyroidectomy: importance of reduced thyroid hormones.
Topics: Adult; Aged; Aged, 80 and over; Bone Density; Calcitriol; Calcium; Collagen; Collagen Type I; Female | 2001 |
Bone mass after long-term euthyroidism in former hyperthyroid women treated with (131)I influence of menopausal status.
Topics: Absorptiometry, Photon; Aged; Biomarkers; Body Mass Index; Bone Density; Cross-Sectional Studies; Fe | 2001 |
Inappropriate secretion of thyrotropin: discordance between the suppressive effects of corticosteroids and thyroid hormone.
Topics: Acromegaly; Female; Growth Hormone; Humans; Hyperthyroidism; Menopause; Methimazole; Middle Aged; Pr | 1979 |
[Pituitary response to synthetic LH-RH stimulus in patients with hypothyroidism, before and after treatment with thyroxine and triiodothyronine].
Topics: Adolescent; Adult; Female; Gonadotropin-Releasing Hormone; Humans; Hypothalamus; Hypothyroidism; Mal | 1978 |
Serum thyrotrophin, prolactin and growth hormone, response to TRH during oestrogen treatment.
Topics: Adult; Aged; Estradiol; Estrogens; Female; Follicle Stimulating Hormone; Growth Hormone; Humans; Lut | 1977 |
Medical adrenalectomy with aminoglutethimide: clinical studies in postmenopausal patients with metastatic breast carcinoma.
Topics: Adrenal Cortex; Adrenalectomy; Aldosterone; Aminoglutethimide; Androstenedione; Bone Neoplasms; Brea | 1978 |
Influence of thyrotropin-releasing hormone on the postmenopausal female.
Topics: Administration, Oral; Estradiol; Estrone; Female; Follicle Stimulating Hormone; Humans; Luteinizing | 1975 |
Twenty-four-hour preoperative endocrine profiles in women with benign and malignant breast disease.
Topics: Adult; Breast Neoplasms; Circadian Rhythm; Estradiol; Female; Follicle Stimulating Hormone; Follicul | 1977 |
Further report on prophylatic lithium in recurrent affective disorders.
Topics: Adult; Affective Symptoms; Age Factors; Aged; Bipolar Disorder; Bone and Bones; Calcium; Female; Hos | 1975 |
Pituitary secretion of free alpha and beta subunit of human thyrotropin in patients with thyroid disorders.
Topics: Adult; Age Factors; Aged; Apoproteins; Female; Follicle Stimulating Hormone; Humans; Hypothyroidism; | 1975 |
Long-term thyroxine treatment and bone mineral density.
Topics: Absorptiometry, Photon; Adult; Aged; Alkaline Phosphatase; Body Mass Index; Bone Density; Calcium; C | 1992 |
Role of ovarian sex steroids in the regulation of thyrotropin (TSH) secretion of hypogonadal women.
Topics: Administration, Oral; Estradiol; Female; Humans; Hypogonadism; Menopause; Middle Aged; Progesterone; | 1992 |
The contribution of body composition, substrates, and hormones to the variability in energy expenditure and substrate utilization in premenopausal women.
Topics: Adolescent; Adult; Blood Glucose; Body Composition; C-Peptide; Calorimetry; Dehydroepiandrosterone; | 1992 |
Longitudinal study of bone loss after thyroidectomy and suppressive thyroxine therapy in premenopausal women.
Topics: Adult; Bone Density; Bone Resorption; Calcitonin; Female; Humans; Longitudinal Studies; Menopause; M | 1992 |
Episodic thyrotropin (TSH) and prolactin (PRL) secretion during aging in postmenopausal women.
Topics: Aged; Aged, 80 and over; Aging; Female; Humans; Menopause; Middle Aged; Periodicity; Prolactin; Thyr | 1992 |
Bone density and L-thyroxine therapy.
Topics: Bone Density; Female; Humans; Menopause; Thyroxine | 1992 |
Determination of bone mineral density by quantitative computed tomography and single photon absorptiometry in subclinical hyperthyroidism: a risk of early osteopaenia in post-menopausal women.
Topics: Absorptiometry, Photon; Adult; Aged; Aged, 80 and over; Bone Density; Bone Diseases, Metabolic; Calc | 1992 |
Low-dose aminoglutethimide in postmenopausal breast cancer: effects on adrenal and thyroid hormone secretion.
Topics: 17-alpha-Hydroxyprogesterone; Adrenocorticotropic Hormone; Aminoglutethimide; Androstenedione; Breas | 1991 |
Skeletal integrity in premenopausal and postmenopausal women receiving long-term L-thyroxine therapy.
Topics: Adult; Aged; Aged, 80 and over; Bone Density; Female; Femur; Femur Neck; Follow-Up Studies; Graves D | 1991 |
Thyroxine replacement therapy--too much of a good thing?
Topics: Bone Density; Drug Administration Schedule; Female; Humans; Hypothyroidism; Menopause; Thyrotropin; | 1990 |
Bone mineral density in postmenopausal women treated with L-thyroxine.
Topics: Aged; Bone Density; Calcitonin; Female; Femur Neck; Humans; Hyperthyroidism; Lumbar Vertebrae; Menop | 1991 |
A therapeutic dilemma: suppressive doses of thyroxine significantly reduce bone mineral measurements in both premenopausal and postmenopausal women with thyroid carcinoma.
Topics: Adult; Bone Density; Carcinoma; Female; Humans; Menopause; Middle Aged; Thyroid Neoplasms; Thyroxine | 1991 |
Effect of toremifene on clinical chemistry, hematology and hormone levels at different doses in healthy postmenopausal volunteers: phase I study.
Topics: Adult; Alanine Transaminase; Animals; Aspartate Aminotransferases; Dose-Response Relationship, Drug; | 1990 |
Reversible impairment of gonadotropin secretion in critical illness. Observations in postmenopausal women.
Topics: Aged; Aged, 80 and over; Critical Care; Female; Follicle Stimulating Hormone; Humans; Length of Stay | 1989 |
Relationship between the levels of serum thyroid hormones or estrogen status and the risk of breast cancer genesis in Japanese women.
Topics: Adult; Breast Neoplasms; Estradiol; Female; Humans; Japan; Menopause; Middle Aged; Random Allocation | 1989 |
Mild hyperthyroidism with inappropriate secretion of TSH in postmenopausal women.
Topics: Female; Humans; Hyperthyroidism; Hypothalamo-Hypophyseal System; Menopause; Middle Aged; Thyroid Gla | 1986 |
Subnormal prolactin responsiveness to thyrotropin-releasing hormone (TRH) in women with primary empty sella syndrome.
Topics: Adenoma; Adult; Empty Sella Syndrome; Female; Humans; Menopause; Middle Aged; Pituitary Neoplasms; P | 1987 |
Long-term L-thyroxine therapy is associated with decreased hip bone density in premenopausal women.
Topics: Adult; Age Factors; Bone Diseases, Metabolic; Female; Femur; Femur Neck; Humans; Lumbar Vertebrae; M | 1988 |
[Thyrotropic-thyroid function in women with uterine hemorrhages in the premenopause].
Topics: Adult; Climacteric; Female; Humans; Menopause; Middle Aged; Thyroid Gland; Thyrotropin; Thyroxine; T | 1988 |
The effect of tamoxifen therapy on thyroid function tests.
Topics: Breast Neoplasms; Female; Humans; Menopause; Middle Aged; Tamoxifen; Thyroid Function Tests; Thyroid | 1986 |
Gonadotropin determinations and thyrotropin-releasing hormone and luteinizing hormone-releasing hormone testing in critically ill postmenopausal women with hypothyroxinemia.
Topics: Adult; Aged; Critical Care; Female; Follicle Stimulating Hormone; Gonadotropin-Releasing Hormone; Go | 1985 |
Prolactin and thyrotropin response to thyrotropin-releasing hormone in premenopausal women with fibrocystic disease of the breast.
Topics: Adult; Estradiol; Female; Fibrocystic Breast Disease; Humans; Kinetics; Menopause; Middle Aged; Prol | 1985 |
Thyroid hormone-binding inhibitor in normal, pregnant, and lactating rat and postmenopausal human breast tissue.
Topics: Animals; Breast; Female; Humans; Kinetics; Lactation; Mammary Glands, Animal; Menopause; Pregnancy; | 1985 |
Decrease of circulating level of SHBG in postmenopausal obese women as a risk factor in breast cancer: reversible effect of weight loss.
Topics: Aged; Androstenedione; Body Weight; Breast Neoplasms; Estradiol; Estrone; Female; Humans; Hydrocorti | 1986 |
The hypercarotenemia in anorexia nervosa: a comparison of vitamin A and carotene levels in various forms of menstrual dysfunction and cachexia.
Topics: 17-Hydroxycorticosteroids; Adolescent; Adult; Aged; Anorexia Nervosa; Cachexia; Carotenoids; Contrac | 1974 |
Endocrine studies in patients with the "empty sella syndrome".
Topics: 17-Hydroxycorticosteroids; 17-Ketosteroids; Acromegaly; Adult; Arginine; Basal Metabolism; Cerebral | 1969 |
Letter: Replacement treatment of hypothyroidism.
Topics: Female; Humans; Hyperthyroidism; Hypothyroidism; Menopause; Osteoporosis; Thyroid Hormones; Thyrotro | 1974 |
Evaluation of thyroid status with "effective thyroxine ratio" (E.T.R.).
Topics: Adolescent; Adult; Aged; Aspirin; Depression, Chemical; Estrogens; Evaluation Studies as Topic; Fema | 1974 |
Conjugated estrogen therapy and tests of thyroid function.
Topics: Dose-Response Relationship, Drug; Estrogens, Conjugated (USP); Female; Humans; Menopause; Protein Bi | 1974 |
Competitive ligand-binding assay for measurement of sex hormone-binding globulin (SHBG).
Topics: Adult; Aged; Binding, Competitive; Dihydrotestosterone; Estradiol; Female; Hirsutism; Humans; Hypert | 1973 |
[Free urinary thyroxine].
Topics: Adult; Breast Neoplasms; Castration; Chromatography, Gel; Diethylstilbestrol; Evaluation Studies as | 1973 |
Physiological evidence of hypermetabolism in osteogenesis imperfecta.
Topics: Adolescent; Age Factors; Basal Metabolism; Body Temperature; Body Weight; Cardiac Output; Child; Chi | 1972 |